(R)-3-((叔丁氧羰基)氨基)-4-(间甲苯基)丁酸, 99%

(R)-3-((tert-Butoxycarbonyl)amino)-4-(m-tolyl)butanoic acid

LSKL, 血小板反应蛋白抑制剂 (TSP-1), BR

LSKL, Inhibitor of Thrombospondin TSP-1;Leu-Ser-Lys-Leu; LSKL

Rat CGRP-(8-37) , >99%

Rat CGRP-(8-37),VTHRLAGLLSRSGGVVKDNFVPTNVGSEAF

((苄氧基)甲基)三氟硼酸钾, 98%

Potassium ((benzyloxy)methyl)trifluoroborate

(1alpha,4alpha,4aalpha,9aalpha)-1,4,4a,9a-四氢-4a-甲基-1,4-甲桥蒽-9,10-二酮, 98%

(1R,4S,4aR,9aS)-rel-4a-Methyl-1,4,4a,9a-tetrahydro-1,4-methanoanthracene-9,10-dione

乙酰苯吖嗪, 98%

Acetophenone Azine

羰基氰酯-3-氯苯基腙, 99%

Carbonyl cyanide 3-chlorophenylhydrazone

(((1R,4R)-4-氰基环己基)甲基)氨基甲酸 叔丁酯, 99%

TRANS-4-N-BOC-AMINOMETHYL-CYCLOHEXANECARBONITRILE

(2-羟基丙基)二甲基胺盐酸盐, 98%

1-(dimethylamino)propan-2-ol hydrochloride

(2S)-2-氨基丁酸甲酯盐酸盐, 98%

(S)-Methyl 2-aminobutanoate hydrochloride

(4R,5S,6S)-3-[[(3S,5S)-5-[(二甲基氨基)甲酰基-1-[[(4-硝基苄基)氧]羰基]-3-吡咯烷基]硫]-6-[(1R)-1-羟乙基]-4-甲基-7-氧代-1-氮杂双环[3.2.0]庚-2-烯-2-羧酸 4-硝基苄基酯, 99%

Meropenem p-nitrobenzyl diester

(6R,7R)-二苯甲基 3-羟基-8-羰基-7-(2-苯基乙酰氨基)-5-硫代-1-氮杂二环[4.2.0]辛-2-烯-2-羧酸酯, 98%

(6R,7R)-Benzhydryl 3-hydroxy-8-oxo-7-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

(9H-芴-9-基)甲基哌嗪-1-羧酸盐酸盐, 99%

(9H-Fluoren-9-yl)methyl piperazine-1-carboxylate hydrochloride

(反式-4-(氨基甲基)环己基)氨基甲酸叔丁酯盐酸盐, ≥98%

tert-Butyl (trans-4-(aminomethyl)cyclohexyl)carbamate hydrochloride

1,1,2-三羧酸三叔丁基肼, 98%

1,1,2-Tris(tert-butoxycarbonyl)hydrazine

1,4,7,10-四氮杂环十二烷-1,4,7-三(乙酸)-10-(2-硫乙基)乙酰胺, 99%

DO3A-Thiol

1-(4-羧基苯)-1,2,2-三苯乙烯, 98%

1-(4-Carboxyphenyl)-1,2,2-triphenylethene

2-亚环丁基乙酸乙酯, 98%

Ethyl 2-cyclobutylideneacetate

S,S-二甲基-N-(对甲苯磺酰基)磺基肟, 98%

S,S-Dimethyl-N-(P-Toluenesulfonyl)Sulfoximine

二苯乙酮肟, ≥99%

1,2-Diphenyl-1-ethanone oxime